Catherine Madigan - Mar 1, 2022 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
3
Date filed
3/3/2022, 03:18 PM
Next filing
Feb 3, 2023

No securities are beneficially owned.